---
figid: PMC9545784__FCP-36-790-g003
pmcid: PMC9545784
image_filename: FCP-36-790-g003.jpg
figure_link: /pmc/articles/PMC9545784/figure/fcp12782-fig-0005/
number: FIGURE 5
figure_title: ''
caption: Effect of EDB on the expression of Bcl‐2, Bax, and Caspase 3 in the hippocampus
  in mice with cerebral ischemia reperfusion injury evaluated by western blot. **P < 0.05;
  **P < 0.01; ns no statistical significance. Bcl‐2, B cell lymphoma 2; Bax, Bcl‐2‐associated
  X; n = 6 mice per group
article_title: Edaravone dexborneol protects cerebral ischemia reperfusion injury
  through activating Nrf2/HO‐1 signaling pathway in mice.
citation: Lili Xu, et al. Fundam Clin Pharmacol. 2022 Oct;36(5):790-800.
year: '2022'

doi: 10.1111/fcp.12782
journal_title: Fundamental & Clinical Pharmacology
journal_nlm_ta: Fundam Clin Pharmacol
publisher_name: John Wiley and Sons Inc.

keywords:
- cerebral ischemia reperfusion injury
- Edaravone dexborneol
- inflammation
- NADPH oxidase 2
- Nrf2/HO‐1 pathway

---
